Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
- Revenue in DKK (TTM)15.55bn
- Net income in DKK3.09bn
- Incorporated2000
- Employees6.64k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Mergers & acquisitions
| Acquired company | NZYM B:CPH since announced | Transaction value |
|---|---|---|
| Synergia Life Sciences Pvt Ltd | -10.11% | 151.86m |
Data delayed at least 15 minutes, as of May 17 2022 08:42 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imcd NV | 25.56bn | 1.54bn | 55.06bn | 3.74k | 35.67 | 5.07 | 24.66 | 2.15 | 3.64 | 3.64 | 60.35 | 25.64 | 1.15 | 6.02 | 6.31 | 918,516.10 | 6.95 | 5.64 | 9.71 | 7.82 | 21.38 | 20.28 | 6.03 | 4.65 | 0.81 | 14.84 | 0.4334 | 44.47 | 23.80 | 14.91 | 72.55 | 23.22 | 23.72 | 24.12 |
| Oci NV | 53.96bn | 6.32bn | 55.99bn | 3.72k | 8.87 | 2.95 | 3.05 | 1.04 | 4.02 | 4.02 | 34.37 | 12.12 | 0.7746 | 12.88 | 8.47 | 1,952,091.00 | 17.22 | 1.83 | 27.23 | 2.58 | 31.25 | 20.65 | 22.23 | 4.15 | 1.30 | 13.68 | 0.4298 | -- | 81.88 | 27.08 | 421.05 | 27.71 | -19.49 | -- |
| Arkema SA | 75.75bn | 11.15bn | 61.91bn | 20.20k | 5.74 | 1.22 | 3.96 | 0.8173 | 19.52 | 19.52 | 133.34 | 91.43 | 0.8319 | 6.11 | 6.31 | 527,324.50 | 12.36 | 6.63 | 15.12 | 8.07 | 23.95 | 21.78 | 14.85 | 7.98 | 1.31 | 26.21 | 0.3238 | 27.67 | 20.74 | 4.79 | 325.33 | 24.81 | 9.62 | 7.91 |
| Chr Hansen Holding A/S | 8.52bn | 1.65bn | 69.80bn | 3.95k | 42.55 | 5.71 | 28.96 | 8.19 | 12.44 | 48.23 | 64.45 | 92.72 | 0.3592 | 3.46 | 6.92 | 2,160,046.00 | 6.94 | 10.12 | 8.86 | 12.73 | 56.50 | 57.40 | 19.31 | 21.61 | 0.6974 | 11.42 | 0.3764 | 61.35 | 11.07 | 2.57 | -14.21 | 1.57 | 14.83 | 20.14 |
| Umicore SA | 178.99bn | 4.61bn | 69.89bn | 13.64k | 14.90 | 2.95 | 9.73 | 0.3905 | 2.56 | 2.56 | 99.41 | 12.91 | 2.77 | 8.05 | 13.71 | 1,763,651.00 | 7.21 | 4.89 | 12.03 | 8.12 | 6.47 | 6.51 | 2.61 | 1.84 | 0.8833 | 12.69 | 0.4049 | 35.61 | 16.15 | 18.16 | 374.19 | 27.87 | 7.67 | 3.83 |
| Brenntag SE | 117.44bn | 4.47bn | 79.81bn | 17.21k | 17.87 | 2.52 | 11.34 | 0.6796 | 3.89 | 3.89 | 102.20 | 27.56 | 1.59 | 8.36 | 6.67 | 915,705.50 | 6.21 | 5.51 | 9.31 | 7.66 | 23.14 | 22.24 | 3.90 | 3.52 | 0.9808 | 13.04 | 0.3981 | 41.72 | 21.94 | 6.50 | -3.90 | 4.47 | 7.50 | 6.67 |
| Akron PAO | 18.87bn | 6.43bn | 81.08bn | 11.21k | 11.60 | 7.57 | 10.36 | 4.30 | 1,562.54 | 1,562.54 | 4,595.30 | 2,395.29 | 0.7354 | 2.99 | 21.09 | -- | 25.34 | 8.40 | 35.98 | 12.17 | 59.90 | 47.34 | 34.46 | 15.83 | 1.10 | -- | 0.4489 | 81.99 | 4.38 | 5.43 | -86.33 | -26.95 | 3.50 | -19.73 |
| Yara International ASA | 139.92bn | 9.95bn | 82.58bn | 17.80k | 8.33 | 1.41 | 4.97 | 0.5902 | 53.32 | 53.32 | 750.87 | 314.17 | 1.12 | 4.23 | 8.56 | 10,765,260.00 | 7.57 | 2.81 | 10.32 | 3.57 | 27.13 | 26.57 | 6.78 | 3.50 | 0.7444 | -- | 0.3365 | 150.29 | 43.36 | 7.93 | -35.02 | -9.93 | -12.00 | 23.39 |
| Evonik Industries AG | 119.76bn | 6.46bn | 86.76bn | 33.15k | 13.46 | 1.15 | 6.06 | 0.7244 | 1.86 | 1.87 | 34.52 | 21.84 | 0.7232 | 4.87 | 7.92 | 487,668.20 | 3.99 | 3.35 | 4.97 | 4.01 | 26.47 | 28.76 | 5.52 | 5.13 | 0.8003 | 29.42 | 0.2889 | 79.08 | 22.59 | 3.27 | 52.97 | 0.00 | -1.54 | 0.3454 |
| Novozymes A/S | 15.55bn | 3.09bn | 97.20bn | 6.64k | 38.71 | 10.49 | 21.43 | 6.25 | 11.05 | 11.05 | 55.54 | 40.79 | 0.6621 | 2.42 | 4.89 | 2,513,907.00 | 13.20 | 15.36 | 17.93 | 20.13 | 56.95 | 57.03 | 19.93 | 21.41 | 0.7552 | 19.29 | 0.3864 | 46.70 | 6.70 | 1.12 | 11.36 | 0.6217 | 0.3917 | 6.58 |
| Akzo Nobel NV | 73.29bn | 5.64bn | 106.38bn | 32.90k | 19.05 | 2.56 | 12.43 | 1.45 | 4.13 | 4.18 | 53.84 | 30.80 | 0.6782 | 3.80 | 4.02 | 300,274.40 | 5.48 | 4.02 | 7.99 | 5.65 | 39.10 | 42.73 | 8.08 | 6.61 | 0.9578 | 30.76 | 0.4781 | 65.07 | 12.39 | 0.3223 | 29.20 | 9.04 | -14.60 | 1.30 |
| PhosAgro PAO | 46.41bn | 14.31bn | 109.41bn | 25.00k | 7.64 | -- | 6.26 | 2.36 | 1,001.52 | 1,001.52 | 3,247.01 | -- | -- | -- | -- | -- | -- | 16.47 | -- | 21.01 | 47.75 | 45.80 | 30.84 | 18.21 | -- | 42.99 | -- | 91.15 | 65.63 | 17.50 | 665.99 | 16.71 | 3.57 | 47.68 |
Data as of May 17 2022. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
19.91%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2021 | 8.06m | 3.55% |
| MFS International (UK) Ltd.as of 28 Feb 2022 | 7.35m | 3.24% |
| Baillie Gifford & Co.as of 12 May 2022 | 6.56m | 2.89% |
| The Vanguard Group, Inc.as of 05 May 2022 | 5.14m | 2.26% |
| BlackRock Fund Advisorsas of 04 May 2022 | 3.75m | 1.65% |
| Impax Asset Management Ltd.as of 31 Mar 2022 | 3.04m | 1.34% |
| Harding Loevner LPas of 31 Mar 2022 | 3.02m | 1.33% |
| Canada Pension Plan Investment Boardas of 31 Mar 2021 | 2.87m | 1.27% |
| Walter Scott & Partners Ltd.as of 31 Mar 2022 | 2.83m | 1.25% |
| Handelsbanken Fonder ABas of 30 Apr 2022 | 2.63m | 1.16% |
More ▼
Data from 31 Dec 2021 - 31 Mar 2022Source: FactSet Research Systems Inc.
